HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Shoji Kudoh Selected Research

pirfenidone

11/2015Risk factors for acute exacerbation of idiopathic pulmonary fibrosis - Extended analysis of pirfenidone trial in Japan.
11/2015Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan.
9/2015All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis.
1/2011The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial.
1/2011Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment.
5/2005Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Shoji Kudoh Research Topics

Disease

23Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2014 - 06/2003
19Lung Neoplasms (Lung Cancer)
10/2012 - 06/2003
18Neoplasms (Cancer)
10/2012 - 02/2003
15Idiopathic Pulmonary Fibrosis
11/2015 - 02/2005
14Interstitial Lung Diseases (Interstitial Lung Disease)
12/2015 - 08/2003
12Inflammation
06/2013 - 06/2002
10Lung Injury
11/2014 - 06/2002
10Infection
12/2013 - 01/2002
9Adenocarcinoma
10/2012 - 06/2003
7Fibrosis (Cirrhosis)
03/2010 - 06/2002
6Pulmonary Fibrosis (Hamman Rich Syndrome)
01/2012 - 10/2002
6Pneumonia (Pneumonitis)
09/2011 - 10/2002
5Acute Lung Injury
01/2010 - 06/2002
5Neoplasm Metastasis (Metastasis)
12/2007 - 02/2003
4Tuberculosis (Tuberculoses)
08/2013 - 01/2002
3Colorectal Neoplasms (Colorectal Cancer)
12/2015 - 08/2003
3Lung Diseases (Lung Disease)
08/2014 - 06/2013
3Idiopathic Interstitial Pneumonias
01/2014 - 01/2011
3Chronic Obstructive Pulmonary Disease (COPD)
08/2012 - 06/2008
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2011 - 06/2003
3Cough
01/2011 - 01/2007
3Sarcoidosis (Schaumann Disease)
04/2009 - 01/2002
3Respiratory Insufficiency (Respiratory Failure)
04/2006 - 11/2004
2Dyspnea (Shortness of Breath)
11/2015 - 01/2011
2Multiple Myeloma
02/2014 - 12/2011
2Drug Toxicity (Drug Safety)
07/2013 - 08/2012
2Human Influenza (Influenza)
01/2011 - 12/2002
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2011 - 01/2010
2Pain (Aches)
01/2011 - 01/2010
2Vascular Diseases (Vascular Disease)
10/2010 - 04/2009
2Genetic Predisposition to Disease (Genetic Predisposition)
06/2009 - 05/2006
2Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
04/2009 - 01/2009
2Cystic Fibrosis (Mucoviscidosis)
08/2008 - 11/2004
2Sleep Apnea Syndromes (Sleep Apnea)
03/2008 - 09/2004
2Chronic Bronchitis
01/2008 - 11/2004
2Pulmonary Eosinophilia (Eosinophilic Pneumonia)
03/2007 - 01/2005
2Rheumatoid Arthritis
01/2007 - 01/2005
1Renal Cell Carcinoma (Grawitz Tumor)
08/2013
1Hepatocellular Carcinoma (Hepatoma)
08/2013

Drug/Important Bio-Agent (IBA)

11gefitinib (Iressa)FDA Link
09/2012 - 08/2003
9Epidermal Growth Factor Receptor (EGF Receptor)IBA
11/2014 - 08/2003
9Diffuse panbronchiolitisIBA
06/2012 - 01/2002
7MacrolidesIBA
12/2013 - 01/2002
7Cisplatin (Platino)FDA LinkGeneric
03/2012 - 04/2004
7Bleomycin (Blenoxane)FDA LinkGeneric
01/2012 - 06/2002
6pirfenidoneIBA
11/2015 - 05/2005
6Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2014 - 11/2007
6Carboplatin (JM8)FDA LinkGeneric
04/2011 - 01/2006
5erlotinib (CP 358,774)FDA Link
12/2014 - 08/2012
5Biological Markers (Surrogate Marker)IBA
01/2014 - 01/2006
51-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
06/2013 - 06/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2011 - 01/2002
5Paclitaxel (Taxol)FDA LinkGeneric
01/2011 - 01/2006
4CollagenIBA
10/2010 - 04/2008
4Complementary DNA (cDNA)IBA
01/2009 - 06/2003
4Messenger RNA (mRNA)IBA
11/2007 - 06/2002
3OxygenIBA
11/2015 - 01/2008
3Erythromycin (Erycette)FDA LinkGeneric
08/2014 - 06/2002
3Vehicle Emissions (Emissions, Vehicle)IBA
06/2013 - 06/2007
3AntigensIBA
01/2011 - 05/2006
3docetaxel (Taxotere)FDA Link
06/2010 - 01/2006
3gemcitabineFDA Link
12/2007 - 01/2006
3indium-bleomycinIBA
01/2006 - 12/2002
2bortezomib (Velcade)FDA Link
02/2014 - 12/2011
2lecithinized superoxide dismutaseIBA
01/2014 - 03/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2014 - 03/2010
2Superoxide DismutaseIBA
01/2014 - 08/2003
2GoldIBA
07/2013 - 11/2012
2EM703IBA
06/2013 - 01/2006
2CytokinesIBA
06/2013 - 10/2002
2Anti-Bacterial Agents (Antibiotics)IBA
08/2012 - 07/2008
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2012 - 02/2005
2Ethambutol (Myambutol)FDA LinkGeneric
11/2011 - 08/2011
2Rifampin (Rifampicin)FDA LinkGeneric
11/2011 - 08/2011
2PyrazinamideFDA LinkGeneric
11/2011 - 08/2011
2Isoniazid (Ftivazide)FDA LinkGeneric
11/2011 - 08/2011
2Etoposide (VP 16)FDA LinkGeneric
04/2011 - 12/2007
2MucinsIBA
02/2011 - 05/2009
2Proteins (Proteins, Gene)IBA
01/2011 - 02/2007
2pyranoprofen (pranoprofen)IBA
01/2011 - 01/2010
2Polymyxin B (Aerosporin)FDA LinkGeneric
01/2010 - 01/2006
2SASIBA
03/2008 - 09/2004
2Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)FDA LinkGeneric
01/2008 - 12/2005
2Adenocarcinoma of lungIBA
12/2007 - 08/2007
2vinorelbine (Navelbine)FDA LinkGeneric
06/2007 - 01/2006
2Carrington syndromeIBA
03/2007 - 01/2005
2irinotecan (Camptosar)FDA LinkGeneric
11/2006 - 04/2004
2Transforming Growth Factor beta (TGF-beta)IBA
01/2006 - 02/2005
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2002 - 06/2002
1panitumumab (Vectibix)FDA Link
12/2015
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2015
1cetuximab (Erbitux)FDA Link
11/2014
1Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA
01/2014
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2014
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2014
1Phosphotransferases (Kinase)IBA
08/2013
1sorafenib (BAY 43-9006)FDA Link
08/2013

Therapy/Procedure

8Drug Therapy (Chemotherapy)
10/2012 - 08/2003
4Radiotherapy
10/2012 - 07/2004
2Combination Drug Therapy (Combination Chemotherapy)
06/2010 - 12/2007